Feature Channels: Alzheimer's and Dementia

Filters close
Newswise: 1920_heatlthy-aging-cedars-sinai.jpg?10000
Released: 7-Nov-2024 5:30 PM EST
Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024
Cedars-Sinai

Experts on healthy aging from Cedars-Sinai’s growing Center for Translational Geroscience and Geriatrics Program will present their latest research and clinical advances at The Gerontological Society of America’s (GSA) 2024 Annual Scientific Meeting in Seattle, Nov. 13-16.

Newswise: ASA Press Conference Schedule for Monday, Nov. 18 #ASA187
Released: 7-Nov-2024 12:50 PM EST
ASA Press Conference Schedule for Monday, Nov. 18 #ASA187
Acoustical Society of America (ASA)

The Acoustical Society of America will host two virtual press conferences Monday, Nov. 18. ASA’s 187th meeting will be held online, and reporters are invited to join technical sessions Nov. 19-21. Media are invited to join the virtual press conferences for presentations on dinosaur acoustics, using camp stove waste for new outdoor power sources, predicting Alzheimer’s with in-ear microphones, and more.

   
31-Oct-2024 3:10 PM EDT
Sleepiness During the Day May Be Tied to Pre-dementia Syndrome
American Academy of Neurology (AAN)

Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a study published in the November 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 5-Nov-2024 11:25 AM EST
Trend of Antibiotic Resistance in Alzheimer’s Needs Examining
Alzheimer's Center at Temple University Lewis Katz School of Medicine

A review article entitled “Prevalence of Antibiotic Resistance in Older Adults and Alzheimer’s Disease Patients: A Systematic Review and Meta-Analysis,” is now published in the Journal Alzheimer’s Disease Reports.

Released: 4-Nov-2024 3:20 PM EST
UW–Madison researchers find persistent problems with AI-assisted genomic studies
University of Wisconsin–Madison

University of Wisconsin–Madison researchers are warning that artificial intelligence tools gaining popularity in the fields of genetics and medicine can lead to flawed conclusions about the connection between genes and physical characteristics, including risk factors for diseases like diabetes.The faulty predictions are linked to researchers’ use of AI to assist genome-wide association studies.

Newswise: ETRI, Successful Development of an AI-Based Dementia Prediction Technology
Released: 4-Nov-2024 9:00 AM EST
ETRI, Successful Development of an AI-Based Dementia Prediction Technology
National Research Council of Science and Technology

Electronics and Telecommunications Research Institute (ETRI) is conducting research on the development of an AI technology that can evaluate and predict brain function degeneration and brain-related diseases such as mild cognitive impairment, dementia, etc., by analyzing the speech utterances of the elderly that can be obtained through their daily conversations.

Released: 1-Nov-2024 5:05 PM EDT
StARS, a New Alzheimer’s Research Center, Will Evaluate, Scale Programs for Nationwide Adoption
Johns Hopkins School of Nursing

Faculty at the Center for Equity in Aging at the Johns Hopkins School of Nursing partnered with researchers at University of Minnesota School of Public Health and Emory University Rollins School of Public Health to create StARS, the State Alzheimer’s Research Support Center. The initiative will create a new research support center for Alzheimer’s disease and related dementias (ADRD) to serve as a resource to support the evaluation of dementia care policies, programs, and practices that have potential to improve care coordination and quality that might be scaled for nationwide adoption.

Newswise: Out-of-Pocket Costs Continue to Rise for Neurologic Medications
Released: 31-Oct-2024 12:45 PM EDT
Out-of-Pocket Costs Continue to Rise for Neurologic Medications
Ohio State University Wexner Medical Center

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological diseases – epilepsy, multiple sclerosis (MS), peripheral neuropathy, Alzheimer’s disease and Parkinson’s disease. This is according to research published online in Neurology®, the medical journal of the American Academy of Neurology.

Released: 31-Oct-2024 7:00 AM EDT
Sleep Apnea Contributes to Dementia in Older Adults, Especially Women
Michigan Medicine - University of Michigan

Sleep apnea, a common yet underdiagnosed sleep disorder, contributes to the development of dementia among adults — particularly women, a Michigan Medicine study suggests. At every age level, women with known or suspected sleep apnea were more likely than men to be diagnosed with dementia.

24-Oct-2024 4:05 PM EDT
Costs Still on the Rise for Drugs for Neurological Diseases
American Academy of Neurology (AAN)

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer’s, and Parkinson’s disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 30-Oct-2024 3:50 PM EDT
Study of Chemical Exposure, Dementia Risk Funded by $11M NIH Grant
Perelman School of Medicine at the University of Pennsylvania

By poring over decades worth of data, researchers hope to better determine how pesticides, metals, and exposures to other elements impact Alzheimer’s disease risk

Newswise: Combination Therapy Slows Cognitive Decline, Research Shows
Released: 30-Oct-2024 12:35 PM EDT
Combination Therapy Slows Cognitive Decline, Research Shows
UT Southwestern Medical Center

A novel combination therapy slowed cognitive decline in elderly patients with a history of depression – a major risk factor for developing Alzheimer’s and other forms of dementia, a study led by UT Southwestern Medical Center’s new Chair and Professor of Psychiatry found.

Newswise:  Superspreader Fibrils Caught in the Act
Released: 28-Oct-2024 2:25 AM EDT
Superspreader Fibrils Caught in the Act
Empa, Swiss Federal Laboratories for Materials Science and Technology

In dementia diseases such as Alzheimer's, incorrectly folded proteins accumulate in the brain. Empa researchers have now resolved a particularly active species of protein fibrils with unprecedented precision. The formation of potentially toxic molecules on the surface of protein fibrils was studied from early to late stages spanning over a period of hours.

Newswise: Wayne State Researcher Secures Two Grants From the National Institute on Aging to Address Alzheimer’s Disease
Released: 25-Oct-2024 2:30 PM EDT
Wayne State Researcher Secures Two Grants From the National Institute on Aging to Address Alzheimer’s Disease
Wayne State University Division of Research

A Wayne State University School of Medicine faculty member has been awarded a total of $2.3 million by the National Institute on Aging of the National institutes of Health for two new, concurrent projects that both address questions related to Alzheimer’s disease, a progressive, age-related degenerative brain disease characterized by memory problems, impaired judgment, cognitive issues and changes in personality.

Newswise: FSU Researchers Uncover New Link Between Gut Bacteria and Alzheimer’s Disease
Released: 24-Oct-2024 11:35 AM EDT
FSU Researchers Uncover New Link Between Gut Bacteria and Alzheimer’s Disease
Florida State University

A groundbreaking study by researchers at Florida State University’s Gut Biome Lab has revealed a potential link between an infection caused by gut bacteria and the progression of Alzheimer’s disease.

Newswise: 1920_stem-cells-cedars-sinai.jpg?10000
Released: 24-Oct-2024 11:05 AM EDT
Cell and Gene Therapies Symposium Open to Public
Cedars-Sinai

Clinicians, researchers and the public are invited to learn about stem cell and gene therapies being developed throughout California at the 7th Annual Alpha Clinics Network Symposium, hosted by Cedars-Sinai on Oct. 25.

Not for public release

This news release is embargoed until 24-Oct-2024 7:00 AM EDT Released to reporters: 21-Oct-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Oct-2024 7:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

18-Oct-2024 3:05 PM EDT
Could Poor Sleep in Middle Age Speed Up Brain Aging?
American Academy of Neurology (AAN)

People in early middle age who have poor sleep quality, including having difficulty falling or staying asleep, have more signs of poor brain health in late middle age, according to a study published in the October 23, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Epidemiology Researcher Leads $1.7M Study on Shingrix’s Impact on Dementia, Stroke in Nursing Homes
Released: 22-Oct-2024 12:10 PM EDT
Epidemiology Researcher Leads $1.7M Study on Shingrix’s Impact on Dementia, Stroke in Nursing Homes
University of Delaware

Epidemiology professor Daniel Harris is leading research on the link between shingles and dementia in nursing home residents. The $1.7 million study examines the impact of the Shingrix vaccine on dementia risk and other neurological issues among 3.5 million residents.

Released: 22-Oct-2024 10:20 AM EDT
Minority Aging Study Celebrates 20th Anniversary
RUSH

The Rush Minority Aging Research Study, the longest-running study of aging in Black men and women, celebrated its 20th anniversary by honoring study participants for devoting their time and efforts in helping advance science.



close
2.61259